← Eichor
Study identifier: NCT07478848 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Radiation, Oral Vancomycin, and CAR-T for B-Cell Lymphomas

Condition: Large B Cell Lymphoma · Non Hodgkin Lymphoma (NHL) · Diffuse Large B Cell Lymphoma (DLBCL)  ·  Sponsor: Abramson Cancer Center at Penn Medicine

PhasePhase 1
Planned participants14
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This clinical trial assesses whether it is feasible to use radiation therapy with vancomycin prior to CAR T-cell therapy for patients with large B-cell lymphomas

This description comes directly from the study's public registry record.

Talk to the study team

Rachel Lundberg, PA-C  ·  215-615-5858  ·  rachel.lundberg@pennmedicine.upenn.edu

Megan Jones, MPH  ·  megan.jones1@pennmedicine.upenn.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Abramson Cancer Center, University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07478848